X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs PFIZER - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD PFIZER STRIDES SHASUN LTD/
PFIZER
 
P/E (TTM) x 13.9 24.2 57.4% View Chart
P/BV x 1.9 3.8 48.8% View Chart
Dividend Yield % 0.6 0.8 65.8%  

Financials

 STRIDES SHASUN LTD   PFIZER
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
PFIZER
Mar-16
STRIDES SHASUN LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,4132,724 51.9%   
Low Rs8481,611 52.6%   
Sales per share (Unadj.) Rs353.3440.9 80.1%  
Earnings per share (Unadj.) Rs23.448.7 48.0%  
Cash flow per share (Unadj.) Rs41.075.8 54.1%  
Dividends per share (Unadj.) Rs5.0015.00 33.3%  
Dividend yield (eoy) %0.40.7 63.9%  
Book value per share (Unadj.) Rs320.4462.9 69.2%  
Shares outstanding (eoy) m89.3545.75 195.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.24.9 65.1%   
Avg P/E ratio x48.344.5 108.6%  
P/CF ratio (eoy) x27.628.6 96.4%  
Price / Book Value ratio x3.54.7 75.3%  
Dividend payout %21.430.8 69.4%   
Avg Mkt Cap Rs m100,98899,163 101.8%   
No. of employees `0004.72.9 162.3%   
Total wages/salary Rs m4,9882,758 180.9%   
Avg. sales/employee Rs Th6,730.06,981.7 96.4%   
Avg. wages/employee Rs Th1,063.6954.5 111.4%   
Avg. net profit/employee Rs Th445.5771.1 57.8%   
INCOME DATA
Net Sales Rs m31,56420,170 156.5%  
Other income Rs m1,212857 141.4%   
Total revenues Rs m32,77621,028 155.9%   
Gross profit Rs m5,2134,310 121.0%  
Depreciation Rs m1,5731,239 127.0%   
Interest Rs m1,8035 34,675.0%   
Profit before tax Rs m3,0493,923 77.7%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-37199 -375.2%   
Tax Rs m6891,794 38.4%   
Profit after tax Rs m2,0892,228 93.8%  
Gross profit margin %16.521.4 77.3%  
Effective tax rate %22.645.7 49.4%   
Net profit margin %6.611.0 59.9%  
BALANCE SHEET DATA
Current assets Rs m35,94916,299 220.6%   
Current liabilities Rs m19,4027,594 255.5%   
Net working cap to sales %52.443.2 121.5%  
Current ratio x1.92.1 86.3%  
Inventory Days Days7165 108.6%  
Debtors Days Days12726 492.4%  
Net fixed assets Rs m34,4788,622 399.9%   
Share capital Rs m894458 195.3%   
"Free" reserves Rs m22,60120,722 109.1%   
Net worth Rs m28,63221,180 135.2%   
Long term debt Rs m27,45525 109,819.2%   
Total assets Rs m76,59129,137 262.9%  
Interest coverage x2.7755.5 0.4%   
Debt to equity ratio x1.00 81,236.7%  
Sales to assets ratio x0.40.7 59.5%   
Return on assets %5.17.7 66.3%  
Return on equity %7.310.5 69.4%  
Return on capital %8.219.0 43.0%  
Exports to sales %48.10.1 80,903.4%   
Imports to sales %14.517.5 82.7%   
Exports (fob) Rs m15,19212 126,602.5%   
Imports (cif) Rs m4,5653,526 129.5%   
Fx inflow Rs m16,61252 32,162.4%   
Fx outflow Rs m5,292140 3,780.6%   
Net fx Rs m11,320-88 -12,815.3%   
CASH FLOW
From Operations Rs m7173,436 20.9%  
From Investments Rs m-22,284-6,991 318.8%  
From Financial Activity Rs m29,488-619 -4,765.3%  
Net Cashflow Rs m8,073-4,174 -193.4%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 37.8 7.5 504.0%  
FIIs % 8.6 4.9 175.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 23.7 109.3%  
Shareholders   56,241 85,207 66.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   WYETH LTD  IPCA LABS  NATCO PHARMA  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 21, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS